# DESCRIPTION

## BACKGROUND OF THE INVENTION

## SUMMARY OF THE INVENTION

## DETAILED DESCRIPTION OF THE INVENTION

### Targeting Agent

### Carriers for Therapeutic Agents

### Therapeutic Agents

### Methods

## Targeted Delivery of siRNA to Activated Leukocytes via Antibody Selective to High-Affinity Form of Integrin LFA-1

## Example 2.1

### Gene Silencing by AL-57-NP In Vitro

### Example 2.2

## Discussion

### Integrin LFA-1 as Drug Delivery Target

### Targeted Delivery of Liposomes for Anti-Inflammatory Therapies

### Example 3

